24/7 Patient Assistance: 760-405-8205

Chloe Atreya, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Chloe Atreya graduated the medical school from the Yale University School of Medicine and then she completed her residency program at the University of Washington. A fellowship at the UCSF followed soon after that. Dr. Atreya is specialized in oncology and board certified in internal medicine and medical oncology. She has been practicing medicine for more than 11 years and is affiliated with the San Francisco General Hospital. During her career, she has also contributed to four publications of medical interest.

  • Education & Training


    Yale University School of Medicine

    Medical School


    University of Washington





  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    San Francisco General Hospital

    Languages: English/Spanish

    (415) 206-8000

    1001 Potrero Ave

    San Francisco, California 94110

    Read More

    UCSF Medical Center

    Languages: English/Spanish

    (415) 353-1037

    505 Parnassus Ave

    San Francisco, California 94143

    Read More
  • Publications & Memberships

    Dr. Chloe Atreya has contributed to 3 publications.

    PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival.

    Atreya, C. E.,Sangale, Z.,Xu, N.,Matli, M. R.,Tikishvili, E.,Welbourn, W.,Stone, S.,Shokat, K. M.,Warren, R. S.; Cancer Med. 2013 Oct 25.

    See more >>

    Association of TP53 Mutational Status and Gender with Survival After Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803.

    Warren, R. S.,Atreya, C. E.,Niedzwiecki, D.,Weinberg, V.,Donner, D. B.,Mayer, R. J.,Goldberg, R. M.,Compton, C.,Zuraek, M. B.,Ye, X.,Saltz, L. B.,Bertagnolli, M. M.; Clin. Cancer Res.. 2013 Oct 15.

    See more >>

    Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.

    Ducker, G. S.,Atreya, C. E.,Simko, J. P.,Hom, Y. K.,Matli, M. R.,Benes, C. H.,Hann, B.,Nakakura, E. K.,Bergsland, E. K.,Donner, D. B.,Settleman, J.,Shokat, K. M.,Warre...; Oncogene. 2013 Apr 1.

    See more >>